international clinical trials day
Learning and networking event
Thursday 18 May 2017
1:00pm - 5:00pm
Join us on Thursday, 18 May at the Skin & Cancer Foundation Inc for a special event to mark International Clinical Trials Day 2017.
With an experienced panel of interesting guest speakers, this networking and learning occasion will celebrate the achievements of clinical trials over the years.
Guest speakers include:
dr hugo stephenson
Executive Chairman, DrugDev
Topic: Running trials without making a loss - simple tips for sites and sponsors
As a doctor, technologist, inventor and entrepreneur in the clinical trials industry, Hugo is passionate about using innovate solutions to drive better research and bring more helpful treatments to patients worldwide. While serving as DrugDev's Executive Chairman, he recently returned to his roots as a physician by serving as an active Principal Investigator in his native Australia. In addition, Hugo is the head of the DrugDev Innovation Lab, a technology incubator to develop, guide and scale promising technology solutions for clinical trials - including eConsent, patient portals, eligibility pre-screening and more.
Previous to joining DrugDev, Hugo founded several businesses including MediGuard, the largest online medication monitoring service serving almost 3M patients, Health Research Solutions, an Australian CRO focused on late phase research (acquired by Quintiles in 2002) and MedSeed, a 1990s pioneer of hospital and GP decision support software in the Asia/Pacific region. Hugo served as Senior Vice President at Quintiles from 2002 to 2011, establishing Quintiles’ global late phase operations, in-house CRA capability through global project coordination centers, and distributed drug safety operation across Asia, Europe and the United States.
Hugo values organisations that think out of the box to improve life. He enjoys a wide range of personal and professional interests such as early biotech, consumer health, high power rocketry, metal sculpture, riding motorcycles and magic. Hugo is a frequent speaker at industry events, including SCRS and SCOPE, and was named as one of the PharmaVoice 100 Most Inspiring People in Pharmaceuticals in 2010.
Dr Amy holmes
Research Associate at the Therapeutics Research Centre and the School of Pharmacy and Medical Science, University of South Australia. Currently acting Head of the Therapeutics Research Centre in Adelaide.
Topic: The use of human skin as gold standard for laboratory-based dermatological research, as an alternative to the use of an animal model
Dr Amy Holmes is an early career researcher and has a broad research interest in advancing the dermatological sciences. She was awarded her PhD in biomedical engineering from the Institute of Science and Technology in Medicine at Keele University (UK). Upon completion of her thesis she worked with industry at Dermal Technology Laboratory under Professor John Heylings. She is currently a postdoctoral researcher at the Therapeutics Research Centre at UniSA, South Australia, and is based at the Basil Hetzel Institute for Translational Medicine.
Dr Amy Holmes is interested in developing topical and transdermal drug delivery systems, investigating the potential toxicity of dermally applied compounds, particularly nanomaterials, through percutaneous absorption studies using human skin.
Amy was previously selected to present her research on ‘Novel nanomaterials for enhanced antiseptic efficacy’ to the Parliamentary Scientific Committee at the Houses of Parliament in Westminster, London.
Mr paul white
Chair, Australian Melanoma Consumer Alliance
Topic: Patients, Advocates & Researchers - Collaborating for great outcomes
Paul White is the Chair of the Australian Melanoma Consumer Alliance (AMCA) which is a national body bringing together like consumer agencies across Australia to work in a more collegiate way.
He is also the Consumer representative for the Melbourne Melanoma Project (MMP) and is on the Board of the Australian New Zealand Melanoma Trials Group (ANZMTG).
He has been a guest speaker at many international, national and state forums advocating for co-production in health.
Paul has a passion to bring melanoma advocacy and support to the forefront of the national psyche. Through the network that he works with, the melanoma community has benefited through newsletters, websites, public forums and social media platforms.
Paul and other supporting patients and advocates have provided significant benefits to the melanoma trial landscape across Australia. The consumer representatives provide valued feedback that ensures the trial partnership between researchers, patients and clinicians is open and trusted.
Dr Suzanne Hasthorpe
Manager, Coordinating Office for Clinical Trial Rsearch
Topic: Regulatory approval of clinical trial applications in Victoria
Dr Suzanne Hasthorpe is a senior healthcare business manager, government sector and health and medical research expert. She established a state-wide clinical trials framework for the Department of Health and Human Services to optimise and grow the clinical trials sector in Victoria.
Suzanne represents the Department of Health and Human Services on State and Commonwealth health bodies. Chair of the National Mutual Acceptance Jurisdictional Working Group (under the Australian Health Ministers Advisory Council). She is a management Board member for a global clinical trial initiative under the Organisation of Economic Cooperation and Development, and a Secretariat to Ministerial committees and review bodies in Victoria.
Suzanne also has over 12 years of corporate governance experience as a non-executive Director in the private sector.
Mr Brian wong
Site Activation Management (SAM) Associate, Eli Lilly Australia
Topic: Informed Consent Revolution
Brian Wong is a Sydney-based Site Activation Management (SAM) Associate at Eli Lilly Australia, where he manages site start-up activities for clinical trials across Australia and New Zealand.
He previously monitored clinical trials as a Clinical Research Associate and is currently the Informed Consent Form (ICF) subject matter expert at Eli Lilly – assisting with the development of global ICF training courses and materials. With a Masters in Pharmacy and Diploma of Innovation Management in Science, his focus at Eli Lilly has been on shaping patient care in clinical trials in the midst of technological change.
We are grateful for the support of our sponsors.
Clinical Trials Connect have very generously donated a $200 Gift Card for use at the Crown Conservatory restaurant as a door prize at the event. All you need to do to be in the running is register to attend and come along to the event. Thank you Clinical Trials Connect for your generous donation.